Heart Failure Clinical Trial

LifeVest Trends Validation Protocol

Summary

This study will evaluate the accuracy of data on body position, daily activity, heart rate, 6-minute walk test, and a health survey collected by the wearable cardioverter defibrillator (WCD).

View Full Description

Full Description

This is a multi-center validation study of heart failure patients wearing the LifeVest WCD modified to collect data on body position, activity, heart rate, 6-minute walk test, and a health survey in order to evaluate data accuracy and patient interactions with the device.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Symptomatic heart failure (i.e., New York Heart Association (NYHA) class II or higher)
Evidence of a prior Myocardial Infarction (MI) or dilated cardiomyopathy
Ejection fraction of 35% or less at the start of WCD use
Anticipated to need a WCD for three months or more
At least 18 years of age (over the legal age of providing consent)

Exclusion Criteria:

Use of an implantable cardioverter defibrillator (ICD), recent removal of an ICD, or planned use of an ICD within the next three months
Need for an assistive device for ambulation (wheelchair, walker, or cane)
Use of a unipolar pacemaker
Physical or mental conditions that prevent interaction with or wearing of the device
Advanced directive prohibiting resuscitation
Pregnancy

Study is for people with:

Heart Failure

Estimated Enrollment:

198

Study ID:

NCT02149290

Recruitment Status:

Completed

Sponsor:

Zoll Medical Corporation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 19 Locations for this study

See Locations Near You

Orange County Heart Institute
Orange California, 92868, United States
Cardiac Arrhythmia Service
Boca Raton Florida, 33432, United States
Gwinnett Medical Center
Lawrenceville Georgia, 30046, United States
Lexington Cardiology Consultants
Lexington Kentucky, 40503, United States
Cardiology Institute of Michigan
Flint Michigan, 48507, United States
SUNY Downstate
Brooklyn New York, 11203, United States
Oklahoma Heart Hospital
Oklahoma City Oklahoma, 73120, United States
Erlanger Clinical Research
Chattanooga Tennessee, 37403, United States
Methodist Healthcare Foundation
Memphis Tennessee, 38104, United States
VA Beach General
Virginia Beach Virginia, 23454, United States
Swedish Medical Center
Seattle Washington, 98122, United States
CAMC
Charleston West Virginia, 25304, United States
St. Mary's Medical Center
Huntington West Virginia, 25702, United States
Klinische Abteilung für Kardiologie
Graz , 8036, Austria
Universitats-Herzzentrum Freiburg - Bad Krozingen
Bad Krozingen , 79189, Germany
Kerckhoff-Klinik
Bad Nauheim , , Germany
Medizinische Klinik & Poliklinik II - Kardiologie
Bonn , 53105, Germany
Klinikum Coburg
Coburg , 96450, Germany
Department für Herzinsuffizienz und Devicetherap
Hamburg , , Germany
St. Vinzenz Hospital
Köln , 50733, Germany
Klinik für Innere Medizin III
Villingen-Schwenningen , 78052, Germany

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

198

Study ID:

NCT02149290

Recruitment Status:

Completed

Sponsor:


Zoll Medical Corporation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider